Clinically, anti-MDA5 dermatomyositis is a distinct subtype of inflammatory myopathy characterized by the presence of autoantibodies against MDA5 and is frequently associated with a high risk of rapidly progressive interstitial lung disease. The gene discussed is IFIH1; the disease is interstitial lung disease.